Acumen Pharmaceuticals, Inc. (ABOS) Analyst/Investor Day Transcript

Acumen Pharmaceuticals, Inc. ( ABOS ) Analyst/Investor Day September 16, 2026 10:00 AM EDT Company Participants Alex Braun - VP & Head of Investor Relations Daniel O'Connell - CEO & Director James Doherty - President & Chief Development Officer Eric Siemers - Chief Medical Officer Paul Shughrue Conference Call Participants Pete Stavropoulos - Cantor Fitzgerald & Co., Research Division Jason Zemansky - BofA Securities, Research Division Geoffrey Meacham - Citigroup Inc., Research Division Thomas Shrader - BTIG, LLC, Research Division Dev Prasad - Lucid Capital Markets, LLC, Research Division Presentation Operator Good day, and thank you for standing by. Welcome to the Acumen Pharmaceuticals Investor Day Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Alex. Ma'am, please go ahead. Alex Braun VP & Head of Investor Relations Thanks, Michelle. I'm Alex Braun, Head of Investor Relations. And on behalf of the Acumen team, I'd like to welcome everyone to our virtual Investor Day. Today, we intend to take you on a deeper dive into Acumen's value proposition as we near the Phase II readout for our product candidate for the treatment of early Alzheimer's disease, sabirnetug. As a reminder, we will be making forward-looking statements. These statements are subject to risks and uncertainties that may cause actual results to differ materially from those projected. A description of those risks can be found in our most recent 10-Q filing with the SEC. Any forward-looking statements are only as of today's date, and we assume no obligation to update any forward-looking statements made on today's call. Today's speakers will include Dan O'Connell, our Chief Executive Officer, who will briefly touch on the Alzheimer's landscape and potential of a-beta oligomer therapies to treat Alzheimer's disease; Dr. Jim Doherty, our President and Chief Development Officer, who will explain sabirnetug's